Skip to main content
. Author manuscript; available in PMC: 2016 Dec 28.
Published in final edited form as: Cell Stem Cells Regen Med. 2016 May 30;2(2):10.16966/2472-6990.111. doi: 10.16966/2472-6990.111

Table 1.

GNF-6231 treatment improves cardiac recovery post-MI The top eight rows represent mean ± SD values for each parameter and treatment at day 7 and 30. The mean ± SD percent difference between day 7 and day 30 for each mouse (Δ) are listed in the bottom four rows. Statistical difference between parameters in each two columns was determined by unpaired t-test.

Echo parameters Vehicle GNF-6231 p-values
LVIDd (mm) Day 7 3.74 ± 0.60 3.95 ± 0.42 ns; p=0.3229
Day 30 4.32 ± 0.68 3.83 ± 0.45 *p=0.0377
LVIDs (mm) Day 7 2.43 ± 0.55 2.45 ± 0.39 ns; p=0.7378
Day 30 2.84 ± 0.64 2.35 ± 0.38 *p=0.0446
FS% Day 7 35.48 ± 4.65 38.24 ± 4.69 ns; p=0.174
Day 30 34.89 ± 4.86 38.71 ± 4.13 *p=0.0325
EF Day 7 0.72 ± 0.06 0.75 ± 0.06 ns; p=0.149
Day 30 0.71 ± 0.06 0.75 ± 0.05 *p=0.0421
Δ LVIDd% 16.109 ± 8.53 −2.287 ± 12.36 **p=0.0024
Δ LVIDs% 17.198 ± 8.91 −3.011 ± 12.65 **p=0.0015
Δ FS% −1.713 ± 3.59 1.4 ± 2.312 *p=0.0265
Δ EF% −1.723 ± 2.36 0.83 ± 1.25 **p=0.0138
N 7 9